New asthma inhaler ingredient tested in healthy volunteers
NCT ID NCT06433908
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new propellant (HFA-152a) in salbutamol inhalers to see if it works like the current propellant (HFA-134a). Sixty healthy adults aged 18-55 received single doses of salbutamol via both inhalers. The goal was to measure how much drug gets into the blood and how fast. This is early research to support developing a more environmentally friendly inhaler.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
GSK Investigational Site
Groningen, 9728, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can tracking severe asthma over time unlock better treatments?
- Can a new injection help tackle obesity? a safety trial begins
- Can pressurized breathing boost mucus clearance in lung disease?
- Can a simple breathing test unlock the secrets of chronic cough?
- Will a new pill formula absorb the same? a trial puts it to the test